YOU ARE HERE: Home > Guidelines and Clinical Policy > 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation ...

People who reported spending six or more hours on screens outside of school or work had worse blood pressure, cholesterol and body mass index (BMI) compared with those with more limited screen time, ...

The Image and Slide Gallery captures images, videos, or slides which can serve as useful teaching materials in the field of CV medicine.

ACC's Geriatric Cardiology Member Section brings together a multidisciplinary community focused on integrating cardiovascular medicine with the principles of aging science, geriatric syndromes and ...

The European Society of Cardiology (ESC) released three major guideline updates during ESC Congress 2026 related to cardiac rehabilitation, chronic kidney disease (CKD) and heart failure (HF). The ...

The U.S. Food and Drug Administration (FDA) has approved baxdrostat, a first-in-class oral aldosterone synthase inhibitor, as an add-on therapy for hypertension in adults whose blood pressure (BP) is ...

A robust body of observational and Mendelian randomization data establishes a causal relationship between elevated Lp(a) and ASCVD, ischemic stroke and calcific aortic valve stenosis (CAVS). 3 A ...

Older patients with coronary artery disease (CAD) for whom PCI was deferred until after TAVI had similar outcomes as those for whom it was not deferred, according to findings from the PRO-TAVI study ...

Spironolactone, an aldosterone blocker, compared with placebo, did not show any significant improvement in terms of heart failure (HF) hospitalizations and cardiovascular death at 24 months in ...

Sleep is a critical physiological process that allows the body to rest, repair and rejuvenate and it has profound implications for systemic health, particularly the cardiovascular system. Along with ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular benefits beyond weight loss, including reducing risk of death, reducing ...

The newest clinical guideline released by the ACC and the American Heart Association (AHA) provides new and updated recommendations for preventing and optimally managing atrial fibrillation (AFib).